Avraham Gabay serves as Executive at ORAMED PHARMACEUTICALS INC., where they oversee executive responsibilities. Since joining the company, Avraham Gabay has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 21, 2024 involved receiving (via award) 140,040 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 21, 2024 | ORMP | $0 | Award | 140,040 | $N/A | Discretionary |
Avraham Gabay currently holds 0 shares of ORAMED PHARMACEUTICALS INC. (ORMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Avraham Gabay has been a net neutral trader of ORMP stock. They have purchased $0 and sold $0 worth of shares.
Avraham Gabay's most recent insider trade was on Jun 21, 2024, when they sold 140,040 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted